FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology. Blood serum ST-2 level is measured in the patients. Then, a prognostic coefficient of risk of developing ventricular tachycardia is calculated by formula. Formula is calculated using blood ST-2 values. If the prognostic coefficient according to the blood serum ST-2 level is more than 0.1502, the patient has a high risk of developing paroxysmal ventricular tachycardia.
EFFECT: method enables increasing the effectiveness of the antiarrhythmic therapy in the patients with a high risk of developing ventricular tachycardia, and also allows to optimize selection of patients-candidates for implantation of cardioverter-defibrillator, which will reduce the number of irrationally implanted devices, thereby improving the quality of life of patients and optimizing economic costs.
1 cl, 5 ex, 2 tbl, 1 dwg
